Manufacturers weathered a turbulent 2017, with Brexit uncertainty and questions around productivity just two of the challenges thrown at them.
Blockbuster drugs, formerly the main focus of the pharma industry, are becoming ever rarer, as the industry shifts to more niche therapeutics.
The Made Smarter Review, the former Industrial Digitalisation Review, answers government calls to boost productivity in the UK’s manufacturing sector.
Combatting malnutrition in all its forms – overweight and obesity as well as undernutrition and micronutrient deficiencies – is a global problem.
In Europe every year, millions of tonnes of sugar beet pulp are re-used as low-value products like animal feed and fertiliser, or processed into green gas.
Seventy years ago, in July 1948, the UK National Health Service (NHS) was founded on a unique set of principles: to provide comprehensive healthcare to all, free at the point of delivery.
Inconsistent and confused generalisations about the relationship between the UK pharmaceutical industry and the NHS have persisted for years.
The cyber-breach of the UK NHS earlier in 2017, which froze computers in hospitals across the country, highlighted the growing problem of cyber-attacks and corporate espionage. Jesse Klebba, CEO of Urgent Technology comments.
New product route definition and commercialisation remain a largely subjective exercise in the pharmaceutical sector.
Graham Mackrell, Managing Director at Harmonic Drive UK, on the increasing market effect of robotics.